AVADEL PHARMACEUTICALS - COM (AVDL)

Historical Holders from Q4 2016 to Q3 2025

Symbol
AVDL on Nasdaq
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
738K
Holdings value
$11.3M
Number of holders
3
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 738K $11.3M $15.27 3
2025 Q2 738K $6.53M $8.85 3
2025 Q1 738K $5.77M +$3.92K $7.83 3
2024 Q4 737K $7.75M -$4.37M $10.51 3
2024 Q3 1.07M $14M -$83.7M $13.12 5
2024 Q2 7.03M $98.8M -$1.02B $14.06 10
2024 Q1 67.7M $1.14B +$203M $16.89 118
2023 Q4 56.1M $792M +$22.5M $14.12 111
2023 Q3 54.3M $559M +$10.5M $10.30 97
2023 Q2 52M $856M +$74.7M $16.48 100
2023 Q1 48.4M $443M +$138M $9.16 89
2022 Q4 33.5M $239M +$16.1M $7.16 83
2022 Q3 31.4M $157M -$10.6M $5.01 73
2022 Q2 33.7M $82.3M -$28.5M $2.44 76
2022 Q1 35.8M $245M -$689K $6.83 78
2021 Q4 34.9M $282M +$4.3M $8.08 80
2021 Q3 32.1M $314M -$2.36M $9.80 81
2021 Q2 32.6M $219M -$1.41M $6.73 78
2021 Q1 32.6M $294M +$1.57M $9.04 77
2020 Q4 32M $214M +$3.68M $6.68 79
2020 Q3 31.5M $159M -$40.7M $5.04 77
2020 Q2 36.3M $293M +$73.4M $8.08 73
2020 Q1 26.9M $211M +$55.7M $7.94 55
2019 Q4 18.4M $139M +$3.41M $7.55 42
2019 Q3 19.4M $80.6M +$264K $4.16 40
2019 Q2 19.3M $55.9M -$533K $2.89 41
2019 Q1 19.6M $28.2M -$885K $1.44 39
2018 Q4 19.8M $51M -$3.33M $2.58 49
2018 Q3 20.2M $88.5M -$2.84M $4.39 63
2018 Q2 20.6M $126M -$36.2M $6.13 67
2018 Q1 25.9M $189M -$4.9M $7.29 72
2017 Q4 26.4M $216M -$17M $8.20 76
2017 Q3 27.2M $285M -$5.5M $10.50 79
2017 Q2 27.7M $306M +$24.7M $11.03 76
2017 Q1 27.9M $270M +$228M $9.68 70
2016 Q4 4.3M $44.7M +$44.7M $10.39 6